GHRP-2

GHRP-2 is a growth hormone secretagogue studied for pulsatile GH release, recovery support, and body-composition signaling.

Profile · 01

Overview

GHRP-2 is a synthetic hexapeptide that stimulates growth hormone release by activating ghrelin or growth-hormone-secretagogue receptors. It is not FDA-approved for any indication, but human studies do exist in GH-deficient populations and healthy volunteers.

The source protocol favors once-daily dosing to balance efficacy with receptor recovery and to avoid the rapid attenuation reported with very frequent administration. This page summarizes that approach for education and research discussion.

At a Glance

Goal
Support pulsatile GH release, recovery, and favorable body-composition signaling
Categories
Growth Hormone SecretagogueBody CompositionRecoveryAnti-Aging
Synergistic
CJC-1295 NO DAC · Ipamorelin · MK-677 · Arginine
Profile · 02

Protocol

Suggested daily titration approach starting low and increasing every two weeks.

Reconstitute
Add 3.0 mL bacteriostatic water to a 5 mg vial for about 1.67 mg/mL concentration
Typical daily range
100-300 mcg once daily
Start
100 mcg daily for Weeks 1-2
Target
200-300 mcg daily by Weeks 5-8+
Frequency
Once per day (subcutaneous)
Cycle Length
8-16 weeks
Timing
Evening dosing is commonly used to align with nocturnal GH rhythms
Route
Subcutaneous
Cycle
8-16 weeks on, 4 weeks off

Inject once daily subcutaneously using the 3.0 mL dilution to keep low doses measurable on a U-100 syringe. The once-daily pattern is meant to reduce acute tachyphylaxis risk seen with overly frequent dosing. Human outcome evidence is still narrower than the GH-response data.

Dose progression

Weeks 1-2
100 mcg (0.1 mg) · 6 units (0.06 mL)
Weeks 3-4
150 mcg (0.15 mg) · 9 units (0.09 mL)
Weeks 5-8+
200 mcg (0.2 mg) · 12 units (0.12 mL)

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Science · 01

How GHRP-2 works.

GHRP-2 activates ghrelin or GH-secretagogue receptors and triggers pulsatile growth-hormone release from the pituitary. Human studies in GH-deficient children and adults confirm meaningful GH increases at relatively low doses.

The source notes that very frequent administration can lead to progressive attenuation, which is why the once-daily pattern is favored here. Broader wellness or anti-aging outcome evidence remains less developed than the endocrine-response data.

Science · 02

Effects

Observations from clinical or preclinical literature.

Supports pulsatile GH release and downstream IGF-1 signaling
May support recovery, sleep quality, and favorable body-composition changes
Clinical GH-response data exist in GH-deficient populations
Generally described as well tolerated at standard research doses
Transient hunger, flushing, or mild injection-site irritation may occur
Long-term human efficacy outside specific endocrine contexts remains under investigation
Science · 03

Caution

Use caution in active cancer or significant cancer history because GH-axis stimulation can be growth-promoting
Not recommended during pregnancy or breastfeeding because safety data is insufficient
Use caution in diabetes or impaired glucose tolerance
Consult a qualified healthcare provider before use if you have chronic endocrine or metabolic disease

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Lifestyle · 01

CoFactors

Arginine
Often discussed as synergistic with GH-secretagogue signaling.
Zinc
Supports GH-related signaling and immune function.
Magnesium
Supports recovery and hormonal regulation.
Vitamin D
Relevant to endocrine balance and recovery physiology.
Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Maintain adequate protein intake and overall nutritional sufficiency to support anabolic signaling
Use resistance training to reinforce recovery and body-composition goals
Prioritize sleep because GH pulses naturally cluster around deep sleep
Manage stress and hydration to support endocrine consistency
Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

  1. Body composition - monitor lean-mass and fat-mass trends over time
  2. Sleep quality and recovery perception - track changes through the cycle
  3. Energy and exercise performance - note improvements or regressions
  4. Injection-site reactions - track redness, swelling, or discomfort
Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

IGF-1
Primary downstream marker of GH-axis activity.
Fasting glucose and HbA1c
Monitor metabolic effects of GH-secretagogue use.
CBC (Complete Blood Count)
General monitoring and baseline screening.
CMP (Comprehensive Metabolic Panel)
Assess liver and kidney function during peptide use.
Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length
Vial size
Bac. water
Syringe
Vials
0 × 5 mg each…
Syringes
0
Bac. water
0 mL
Swabs
02 per syringe
Calculators · 02

Dose Calculator

Dose Calculator

Vial
Bac. water
Syringe
Dose
Concentration
0mcg/mL
Volume per dose
0mL
…
Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

  1. Allow vial to reach room temperature for 15–20 minutes before reconstitution.
  2. Draw the chosen bacteriostatic water volume with a sterile syringe.
  3. Inject slowly down vial wall; avoid foaming.
  4. Gently swirl/roll until dissolved (do not shake).
  5. Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
  6. Use within 30 days; discard any unused solution after 30 days.
Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and injection site with alcohol and allow them to dry
Pinch a skinfold and insert the needle at 45-90 degrees into subcutaneous tissue
Do not aspirate for subcutaneous injections; inject slowly and steadily
Rotate sites systematically across the abdomen, thighs, and upper arms
Discard used syringes immediately in a sharps container

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Practice · 03

Storage

Lyophilized
Store at room temp in dry, dark conditions; minimize moisture exposure.
Reconstituted
Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.
Reference · 01

Notes

Use a new sterile insulin syringe for each injection and dispose of it safely
Smaller 30-unit or 50-unit syringes may improve readability at the lowest doses
The once-daily protocol is intended to limit receptor attenuation from excessive dosing frequency
Clinical decisions should involve qualified healthcare providers when endocrine monitoring is relevant
PepTribe is an educational platform. This information is for research and learning purposes only and is not medical advice.
Reference · 02

References

  1. Journal of Clinical Endocrinology & Metabolism
    Clinical GHRP-2 work in GH-deficient children.
    https://academic.oup.com/jcem
  2. European Journal of Endocrinology
    Daily subcutaneous GHRP-2 administration in healthy young men.
    https://eje.bioscientifica.com
  3. Endocrine
    Acute and chronic GH/IGF-1 response to GHRP-2.
    https://link.springer.com/journal/12020
  4. CDC
    Subcutaneous injection route guidance.
    https://www.cdc.gov/vaccines/hcp/admin/downloads/YCTS-VaxAdmin-Subcut-injection.pdf
  5. WHO (NCBI Bookshelf)
    Injection-safety guidance for subcutaneous administration.
    https://www.ncbi.nlm.nih.gov/books/NBK390474/
On this page